Posts

Patentee's own post-published data undermines the credibility of their broad cat antibody patent (T 0709/23)

Walking the line between broad scope and lack of legal certainty (T 2387/22)

Will functional antibody inventions find new life in the US with mean-plus-function claims? (Ex parte Chamberlain, Appeal No. 2022-001944)

Never Too Late: If you missed the IPKat last week!